Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

Chingiz Underbayev, MD PhD, Inhye E Ahn, MD, Hailey Harris, Lauren T Vaughn, Mehdi Pirooznia, MD PhD, Liqiang Xi, MD, Mark Raffeld, MD, Sarah E. M. Herman, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 1287.

https://doi.org/10.1182/blood-2019-127364

Published: 2019

Journal Articles

The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study

Matthew S. Davids, MD, Bryone J. Kuss, PhD BMBS, FRCPA, FRACP, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Marco Montillo, MD, James Essell, MD, Nicole Lamanna, MD, Zsolt Nagy, MD PhD, Constantine S. Tam, MBBS (Hons), MD FRACP, FRCPA, Stephan Stilgenbauer, Paolo Ghia, MD PhD, Julio Delgado, MD, NgocDiep Le, MD PhD, Stephanie Lustgarten, PhD, David T. Weaver, PhD, Ulrich Jaeger, MD

Blood (2018) 132 (Supplement 1): 3140.

https://doi.org/10.1182/blood-2018-99-117521

Published: 2018

Journal Articles

Confirming the Presence of a Smoldering T and B PLL Associated with Improved 5 Year OS: Using the National Cancer Data Base

Benjamin Parsons, DO, Polewski Peter, MD, Ronald S. Go, MD, Andrew Borgert, Mamatha Gaddam, MD, Swapna Narayana, MD

Blood (2018) 132 (Supplement 1): 5543.

https://doi.org/10.1182/blood-2018-99-120178

Published: 2018

Journal Articles

TP53 Aberrations By FISH in CLL and Complex Karyotype at Transformation Predict for Worse Outcome in Diffuse Large B-Cell Lymphoma - Richter Transformation: A Single Institution Series of 75 DLBCL-RT Cases

Shiraz Fidai, MD, Madina Sukhanova, PhD, Brian C.-H. Chiu, PhD, Y. Lynn Lynn Wang, MD PhD, Wendy Stock, MD, Peter A Riedell, MD, Sonali M. Smith, MD, Elizabeth Hyjek, MD, Girish Venkataraman, MD MBBS

Blood (2018) 132 (Supplement 1): 2984.

https://doi.org/10.1182/blood-2018-99-112242

Published: 2018

Journal Articles

Incidence and Type of Opportunistic Infections during Ibrutinib Treatment at a Single Academic Center

Kerry A. Rogers, MD, Mousa Luay, MD, Qiuhong Zhao, MS, Tracy Wiczer, PharmD, Lauren Levine, PharmD, El Boghdadly Zeinab, MBBCh, James S. Blachly, MD, John C. Byrd, MD, Tomas Guerrero, MD, Jeffrey A. Jones, MD MPH, MBA, Shindiapina Polina, MD PhD, Audrey Sigmund, MD, Matthew Sullivan, MD, Farrukh T. Awan, MD MS, Jennifer A. Woyach, MD

Blood (2017) 130 (Supplement 1): 830.

https://doi.org/10.1182/blood.V130.Suppl_1.830.830

Published: 2017

Journal Articles

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Ming Hong, MD PhD, Shuai Wang, MD PhD, Han Zhu, MD, Rong Wang, Jianyong Li, MD PhD, Guangsheng He, MD PhD

Blood (2017) 130 (Supplement 1): 5230.

https://doi.org/10.1182/blood.V130.Suppl_1.5230.5230

Published: 2017

Journal Articles

Successful Result of 113 Patients for Refractory/Recurrent Leukemia By Allogeneic Hematopoietic Cell Transplantation and Prophylactic Immunotherapy

Jingbo Wang, PhD, Xiaojun Huang, Ying Hu, Song Xue, Haoyu Cheng, Yuming Yin, Weijie Zhang, Jiangying Gu, Junbao He, Fan Yang

Blood (2016) 128 (22): 5856.

https://doi.org/10.1182/blood.V128.22.5856.5856

Published: 2016

Journal Articles

The Landscape of Dynamic Genetic Changes in Ibrutinib-Treated CLL

Dan A. Landau, MD PhD, Clare Sun, MD, Daniel Rosebrock, Mariela Campbell, Sarah E. M. Herman, PhD, Julia Hoellenriegel, MS, Mohammed Farooqui, Wandi Zhang, MD, Donna S. Neuberg, ScD, Dimitri Livitz, Ignaty Leshchiner, Gad Getz, PhD, Jan Burger, MD PhD, Adrian Wiestner, MD PhD, Catherine J Wu, MD

Blood (2016) 128 (22): 188.

https://doi.org/10.1182/blood.V128.22.188.188

Published: 2016

Journal Articles

Evaluation of the Interest of BRAF –V600E Mutation Detection By Arms-qPCR in Hairy Cell Leukemia Diagnosis and Treatment Monitoring

Ouda Ghoual, MDcal Student, Stéphanie Jouve, MDcal Student, Véronique Salaun, Stéphane Cheze, Michele Malet, Xavier Troussard, MD PhD, Dina Istasi, MBBCH, MD CES,DEA

Blood (2014) 124 (21): 2956.

https://doi.org/10.1182/blood.V124.21.2956.2956

Published: 2014

Journal Articles

a Rare Case of Chronic Lymphocytic Leukemia (CLL), Transforming to Two Different Types of Aggressive Lymphoma during the Course of the Disease.

Amir Azadi, MD, Padmini Moffett, MD, Mounika Mandadi, MBBS, Goetz H Kloecker, MD

Blood (2014) 124 (21): 5650.

https://doi.org/10.1182/blood.V124.21.5650.5650

Published: 2014

Journal Articles

Efficacy and Safety of Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia with 17p Deletion: Results from the Phase II RESONATE™-17 Trial

Blood (2014) 124 (21): 327.

https://doi.org/10.1182/blood.V124.21.327.327

Published: 2014

Journal Articles

Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of Eurocord, SFGM-TC and Cqwp-EBMT

Blood (2014) 124 (21): 2581.

https://doi.org/10.1182/blood.V124.21.2581.2581

Published: 2014

Journal Articles

“Hairless” hairy cells

Bushra Moiz, Hira Qadir

Blood (2014) 123 (26): 4013.

https://doi.org/10.1182/blood-2014-03-566307

Published: 2014

Journal Articles

Richter’s Syndrome In Chronic Lymphocytic Leukemia: Clinical and Laboratory Features In 119 Patients, Attempting To Identify Possible Risk Factors

Tamar Tadmor, MD, Riva Fineman, MD, Lev Shvidel, Osnat Bairey, MD, Neta Goldschmidt, MD, Rosa Ruchlemer, Naomi Rahimi Rachimi, MD, Yair Herishanu, MD, Mona Yuklea, MD,, Ariela Arad, MD, Ariel Aviv, MD, Aaron Polliack, MD

Blood (2013) 122 (21): 5281.

https://doi.org/10.1182/blood.V122.21.5281.5281

Published: 2013

Journal Articles

Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival

Voravit Ratanatharathorn, MD, Abhinav Deol, MD, Lois Ayash, MD, Divaya Bhutani, MD, Lawrence G Lum, MD, DSc, Zaid Al-Kadhimi, MD, Muneer H. Abidi, MD, Marie Ventimiglia, Kendra Mellert, Joseph P. Uberti, MD, PhD

Blood (2013) 122 (21): 3300.

https://doi.org/10.1182/blood.V122.21.3300.3300

Published: 2013

Journal Articles

Incidence Of Atypical Chronic Lymphocytic Leukemia In 1819 Patients With B Chronic Lymphoproliferative Disorder

Edouard Cornet, MD, Alice-Sophie Boucher, Véronique Salaun, Florence Truquet, Michele Malet, Dina Naguib, MD, Françoise Galateau-Salle, Xavier Troussard, MD

Blood (2013) 122 (21): 1770.

https://doi.org/10.1182/blood.V122.21.1770.1770

Published: 2013

Journal Articles

The Use Of Donor Lymphocyte Infusion (DLI) For Relapse After Related T-Cell Replete HLA-Haploidentical Bone Marrow Transplantation (haploBMT) With Posttransplantation Cyclophosphamide (PTCy)

Amer M. Zeidan, MD, Patrick Forde, MD, Heather J. Symons, MD, MHS, Allen R. Chen, MD, PhD, MHS, B. Douglas Smith, MD, Ephraim J. Fuchs, Leo Luznik, Richard J. Jones, Javier Bolaños-Meade, MD

Blood (2013) 122 (21): 4629.

https://doi.org/10.1182/blood.V122.21.4629.4629

Published: 2013

Journal Articles

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Anna Ghiso, Annamaria Raiola, Francesca Gualandi, Alida Dominietto, Riccardo Varaldo, Maria Teresa van Lint, Stefania Bregante, Carmen Di Grazia, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Elisabetta Tedone, Andrea P Bacigalupo

Blood (2012) 120 (21): 1950.

https://doi.org/10.1182/blood.V120.21.1950.1950

Published: 2012

Journal Articles

Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?

Eytan M. Stein, MD, Vipul Pareek, MD, David Kudlowitz, Dan Douer, MD, Martin S Tallman, MD

Blood (2012) 120 (21): 1453.

https://doi.org/10.1182/blood.V120.21.1453.1453

Published: 2012

Journal Articles

How I treat prolymphocytic leukemia

Claire Dearden

Blood (2012) 120 (3): 538–551.

https://doi.org/10.1182/blood-2012-01-380139

Published: 2012

NARROW

Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study

Confirming the Presence of a Smoldering T and B PLL Associated with Improved 5 Year OS: Using the National Cancer Data Base

TP53 Aberrations By FISH in CLL and Complex Karyotype at Transformation Predict for Worse Outcome in Diffuse Large B-Cell Lymphoma - Richter Transformation: A Single Institution Series of 75 DLBCL-RT Cases

Incidence and Type of Opportunistic Infections during Ibrutinib Treatment at a Single Academic Center

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Successful Result of 113 Patients for Refractory/Recurrent Leukemia By Allogeneic Hematopoietic Cell Transplantation and Prophylactic Immunotherapy

The Landscape of Dynamic Genetic Changes in Ibrutinib-Treated CLL

Evaluation of the Interest of BRAF –V600E Mutation Detection By Arms-qPCR in Hairy Cell Leukemia Diagnosis and Treatment Monitoring

a Rare Case of Chronic Lymphocytic Leukemia (CLL), Transforming to Two Different Types of Aggressive Lymphoma during the Course of the Disease.

Efficacy and Safety of Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia with 17p Deletion: Results from the Phase II RESONATE™-17 Trial

Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of Eurocord, SFGM-TC and Cqwp-EBMT

“Hairless” hairy cells

Richter’s Syndrome In Chronic Lymphocytic Leukemia: Clinical and Laboratory Features In 119 Patients, Attempting To Identify Possible Risk Factors

Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival

Incidence Of Atypical Chronic Lymphocytic Leukemia In 1819 Patients With B Chronic Lymphoproliferative Disorder

The Use Of Donor Lymphocyte Infusion (DLI) For Relapse After Related T-Cell Replete HLA-Haploidentical Bone Marrow Transplantation (haploBMT) With Posttransplantation Cyclophosphamide (PTCy)

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?

How I treat prolymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only